LifeSignals Receives US FDA Clearance To Market ECG Remote Monitoring Platform
Executive Summary
LifeSignals received 510(k) clearance for its Wireless Medical Biosensor LP1250, which can be integrated into third-party devices to remotely monitor patients for common cardiac arrythmias.
You may also be interested in...
Post-COVID-19 Consumer Preferences A Guide For Pharma Strategy
Post-COVID, a consumer’s home as point of care has led to greater acceptance for health gadgets while shifting preferences away from injectables, shows a new study, which has pointers for pharma strategy. With anxiety over the pandemic continuing, mental telehealth solutions are ripe for the picking, it adds.
COVID-19: LifeSignals, VitalConnect Get Green Light For ECG Remote Monitoring
Two California-based ECG remote monitoring companies see rising demand for their solutions during the COVID-19 crisis.
Menopause Research To Benefit From White House Initiative To Bolster Women’s Health
Women’s health leaders in the menopause space have high hopes that President Biden’s executive order will provide dollars for more research on how hormone therapy can prevent disease and draw attention to the need for provider education on menopausal symptoms.